A Case of Drug-Induced Liver Injury Secondary to Natalizumab. (16th June 2020)

• Record Type: Journal Article
• Authors: Santoiemma, Phillip P.; Maddur, Haripriya; Moore, Christopher M.
• Other Names: Vigano Mauro Academic Editor.
• Is Part Of: Case reports in hepatology. Volume 2020(2020)
• Publication Date: 2020-06-16
• Subjects: Liver -- Periodicals; Liver -- Diseases -- Periodicals; Liver Diseases; Liver; Liver; Liver -- Diseases; Periodicals; Periodicals; Case Reports; Fulltext; Internet Resources; Periodicals; 616.36
• DOI: 10.1155/2020/7976585
• Languages: English
• ISSNs: 2090-6587

Abstract

Abstract : A 33-year-old Caucasian female with relapsing-remitting multiple sclerosis presented with abdominal pain, nausea, and vomiting and was found to have acute liver injury. After thorough investigation, she was diagnosed with drug-induced liver injury (DILI) thought secondary to redosing of Natalizumab therapy.